Figure 7

GSEA and GSVA revealed significantly enriched pathways. GSEA revealed that HYPERTROPHIC_ CARDIOMYOPATHY_ HCM (A), FOCAL_ ADHESION (B), DILATED_ CARDIOMYOPATHY (C), DRUG_ METABOLISM_ CYTOCHROME_ P450 (D), GLUTATHIONE_ METABOLISM (E), and METABOLISM_ OF_ XENOBIOTICS_ BY_ CYTOCHROME_ P450 (F) were significantly enriched. (G) A pathway heatmap demonstrating GSVA enrichment in different risk groups.